Saturday, February 10, 2018

Apalutamide delays progression of nonmetastatic, castration-resistant prostate cancer

A multi-institutional phase 3 trial found that treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy.

from Top Health News -- ScienceDaily http://ift.tt/2nP2DHG
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Preclinical study finds surges in estrogen promote binge drinking in females

The hormone estrogen regulates binge drinking in females, causing them to 'pregame' -- consume large quantities of alcohol in the fi...